<DOC>
	<DOCNO>NCT00655525</DOCNO>
	<brief_summary>The overall goal study examine role fish oil supplementation ameliorate inflammatory state uremia related muscle protein catabolism associate disease state . We hypothesize administered period 3 month , fish oil improve chronic uremic inflammation . We hypothesize fish oil administration improve muscle protein breakdown associate uremia inflammation .</brief_summary>
	<brief_title>Omega-3 Fatty Acid Administration Dialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>Patients CHD 6 month ; Ability read sign consent form ; Have acceptable dialysis adequacy ( Kt/V &gt; 1.2 ) ; Use biocompatible hemodialysis membrane ; Have patent , well function , arteriovenous dialysis access permanent dialysis catheter ( option arteriovenous access ) ; Signs chronic inflammation ( average CRP â‰¥ 5 mg/L 3 consecutive measurement ) Pregnancy ; Intolerance study medication ; Severe , unstable , active , chronic inflammatory disease ( active infection , active connective tissue disorder , active cancer , HIV , liver disease ) ; Diabetes mellitus insulin therapy ; Hospitalization within 1 month prior study ; Malfunctioning arterialvenous vascular access ( recirculation and/or blood flow &lt; 500 ml/min ) ; Patients receive steroid ( &gt; 5 mg/day ) and/or immunosuppressive agent ; Lifeexpectancy le 6 month ; Age le 18 year old ; Atrial fibrillation ( undergoing optional Pulse Wave Velocity ) ; Hypersensitivity organic nitrate , isosorbide , nitroglycerin ( undergo optional brachial artery Doppler ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>inflammation</keyword>
	<keyword>end stage renal disease</keyword>
</DOC>